Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Share-based Compensation (2022 - 2023)

Historic Share-based Compensation for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $804000.0.

  • Lexeo Therapeutics' Share-based Compensation rose 5431.86% to $804000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $12.5 million for FY2024, which is 30992.44% up from last year.
  • According to the latest figures from Q4 2023, Lexeo Therapeutics' Share-based Compensation is $804000.0, which was up 5431.86% from $874000.0 recorded in Q3 2023.
  • Lexeo Therapeutics' 5-year Share-based Compensation high stood at $969000.0 for Q2 2023, and its period low was $397000.0 during Q1 2023.